Seven top upregulated emRNAs and related to ccRCC or/and multiple malignant tumors, including CUL9, ATM, ARID1A, KMT2D, PBRM1, PREX2, and SETD2, were selected as candidate biomarkers for further testing. This evidence concerns the gene CUL9 and nonpapillary renal cell carcinoma.